Pregabalin Capsule
Product Images NDC 80425-0026

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

FDA Label Image

Fig 10

FDA Label Image

Fig 11

FDA Label Image

Fig 12

FDA Label Image

Fig 2

FDA Label Image

Fig 3

FDA Label Image

Fig 4

Percentage Improvement in Pain from Baseline is available. However, the rest of the text is not readable as it seems to be a mix of random characters and numbers.*

FDA Label Image

Fig 5

FDA Label Image

Fig 6

This appears to be a table representing results from multiple studies comparing the effectiveness of various doses of a medication (indicated by the mg amounts) to a placebo. The text indicates that some results are “statistically significant” compared to the placebo. However, without context about the medication or the specific studies, it is difficult to provide further information or interpretation of the results.*

FDA Label Image

Fig 7

FDA Label Image

Fig 9

The text contains a chart showing the percent of patients improved based on different daily doses of Pregabalin and Fiacsto, as well as the percentage improvement in pain from baseline. No further information is available.*

FDA Label Image

Pregabalin 50mg Cap Qty 60 Ndc 80425 0026

FDA Label Image

Pregabalin 50mg Cap Qty 90 Ndc 80425 0026

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.